LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 15 of 15: Calculated dose-response metrics. - Dataset (ID:20252)
Small Molecules Studied
Download: Excel (XLSX), Comma-separated (CSV), Images (Zip file)
| HMS LINCS ID | Name | Alternative Names | LINCS ID | Structure Image | PubChem CID |
|---|---|---|---|---|---|
| 10098-1 | Gefitinib | ZD1839; Iressa | LSM-1098 |  | 123631 |
| 10234-1 | GDC-0980 | RG7422 | LSM-4257 |  | 66694608 |
| 10157-1 | Foretinib | XL880; GSK1363089 | LSM-1158 |  | 42642645 |
| 10141-1 | Fedratinib | SAR 302503; SAR-302503; SAR302503; TG 101348; Tg-101348; TG101348 | LSM-1142 |  | 16722836 |
| 10097-1 | Erlotinib | OSI-774 | LSM-1097 |  | 176870 |
| 10069-1 | Enzastaurin | LY317615 | LSM-1069 |  | 176167 |
| 10127-1 | Dovitinib | TKI_258; TKI258 | LSM-1127 |  | 49830557 |
| 10020-1 | Dasatinib | BMS-354825; Sprycel | LSM-1020 |  | 3062316 |
| 10232-1 | Dactolisib | BEZ235; NVP-BEZ235 | LSM-4255 |  | 11977753 |
| 10027-1 | Crizotinib | PF02341066 | LSM-1027 |  | 11626560 |
| 10010-1 | CP724714 | LSM-42777 |  | 53401057 | |
| 10009-1 | CP466722 | LSM-1009 |  | 44551660 | |
| 10180-1 | CHIR-99021 | CT99021; KIN001-157 | LSM-1181 |  | 9956119 |
| 10025-1 | CGP60474 | MLS000911536; SMR000463552 | LSM-1025 |  | 644215 |
| 10117-1 | Celastrol | LSM-1117 |  | 5315765 | |
| 10120-1 | Canertinib | CI-1033; PD-183805 | LSM-1120 |  | 156414 |
| 10055-1 | BX-912 | LSM-1055 |  | 11754511 | |
| 10147-1 | Buparlisib | BKM120; NVP-BKM120 | LSM-1148 |  | 16654980 |
| 10177-1 | Brivanib | BMS-540215 | LSM-1178 |  | 11451527 |
| 10028-1 | BMS345541 | LSM-1028 |  | 9813758 | |
| 10041-1 | BI-2536 | NPK33-1-98-1 | LSM-1041 |  | 11364421 |
| 10067-1 | Barasertib | AZD1152-HQPA | LSM-1067 |  | 16007391 |
| 10164-1 | AZD8330 | ARRY-424704; ARRY-704 | LSM-1165 |  | 16666708 |
| 10007-1 | AZD8055 | LSM-1007 |  | 25262965 | |
| 10006-1 | AZD7762 | LSM-1006 |  | 67077825 |